Abstract:Objective To investigate the incidence and related influencing factors of Acinetobacter baumannii (AB) and multidrug-resistant AB (MDRAB) infections in the elderly patients after surgical treatment of lung cancer. Methods A retrospective study was conducted on 394 elderly patients undergoing lung cancer resection in our hospital from April 2016 to March 2021. The infection incidence of AB and MDRAB within 8 weeks after surgery were statistically analyzed, and univariate and multivariate logistic regression analyses were used to identify the relevant influencing factors for AB and MDRAB infections. SPSS 22.0 was employed to perform data staticitical analysis. Chi-square test was utilized for inter-group comparison. Results Among the 394 subjected elderly patients, 61 of them (15.48%) developed AB infection, including 28 cases (7.11%) of MDRAB infection. Univariate analysis showed that age, diabetes mellitus, combined use of antibiotics, postoperative stress ulcer, mechanical ventilation and chemoradiotherapy, length of postoperative intensive care unit (ICU) stay, bed-ridden time, and hospital stay length were all associated with MDRAB infection (P<0.05). Multivariate analysis indicated that age, diabetes mellitus, postoperative stress ulcer, mechanical ventilation and chemoradiotherapy, postoperative ICU stay length, length of hospital stay ≥15 d, and postoperative bed-ridden time ≥5 d were independent risk factors for AB infection (P<0.05); diabetes mellitus, postoperative ICU stay length, postoperative stress ulcer, mechanical ventilation and chemoradiotherapy, combined antibiotic use, hospitalization time ≥15 d, and postoperative bed -ridden time ≥5 d were independent risk factors for MDRAB infection (P<0.05). Conclusion The incidence of MDRAB infection is relatively high in elderly lung cancer patients after resection. Its influencing factors include diabetes mellitus, postoperative ICU stay length, combined use of antibiotics, postoperative stress ulcer, mechanical ventilation and chemoradiotherapy, hospitalization time ≥15 d, and postoperative bed-ridden time ≥5 d. In clinical practice, it is necessary to strengthen the control of comorbidities, reduce invasive procedures, and emphasize anti-infection interventions to reduce the incidence of postoperative MDRAB infection in the patients.